J. S. Haukoos, E. Hopkins, A. A. Conroy, et al., “Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in Emergency Department Patients,” Journal of the American Medical Association, Vol. 304, No. 3, 2010, pp. 284-292. doi:10.1001/jama.2010.953
 Centers for Disease Control and Prevention, “Vital Signs: HIV Testing and Diagnosis among Adults—United States, 2001-2009,” Morbidity & Mortality Weekly Report, Vol. 59, No. 47, 2010, pp. 1550-1555.
 G. Marks, N. Crepaz and R. S. Janssen, “Estimating Sexual Transmission of HIV from Persons Aware and Unaware That They Are Infected with the Virus in the USA,” AIDS, Vol. 20, No. 10, 1920, pp. 1447-1450.
 J. Castilla, J. Del Romero, V. Hernando, B. Marincovich, S. Garcia and C. Rodriguez, “Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV,” Journal of Acquired Immune Deficiency Syndromes, Vol. 40, No. 1, 2005, pp. 96-101. doi:10.1097/01.qai.0000157389.78374.45
 B. M. Branson, H. H. Handsfield, M. A. Lampe, et al., “Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings,” Morbidity & Mortality Weekly Report Recommendations & Reports, Vol. 55, No. RR-14, 2006, pp. 1-17.
 R. C. Merchant, G. R. Seage, K. H. Mayer, M. A. Clark, V. G. DeGruttola and B. M. Becker, “Emergency Department Patient Acceptance of Opt-In, Universal, Rapid HIV Screening,” Public Health Reports, Vol. 123, Suppl. 3, 2008, pp. 27-40.
 S. R. Kendrick, K. A. Kroc, E. Couture and R. A. “Weinstein. Comparison of Point-of-Care Rapid HIV Testing in Three Clinical Venues,” AIDS, Vol. 18, No. 16, 2004, pp. 2208-2210. doi:10.1097/00002030-200411050-00017
 P. M. Marzuk, H. Tierney, K. Tardiff, et al., “Increased Risk of Suicide in Persons with AIDS,” Journal of the American Medical Association, Vol. 259, No. 9, 1988, pp. 1333-1337. doi:10.1001/jama.1988.03720090023028
 T. R. Cote, R. J. Biggar and A. L. Dannenberg, “Risk of Suicide among persons with AIDS,” Journal of the American Medical Association, Vol. 268, No. 15, 1992, pp. 2066-2068. doi:10.1001/jama.1992.03490150118035
 A. L. Dannenberg, J. G. McNeil, J. F. Brundage and R. Brookmeyer, “Suicide and HIV Infection. Mortality Follow-Up of 4147 HIV-Seropositive Military Service Applicants,” Journal of the American Medical Association, Vol. 276, No. 21, 1996, pp. 1743-1746.
 G. D. Sanders, A. M. Bayoumi, V. Sundaram, et al., “Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy,” New England Journal of Medicine, Vol. 352, No. 6, 2005, pp. 570-585. doi:10.1056/NEJMsa042657
 N. Segnan, C. Senore, B. Andreoni, et al., “Randomized Trial of Different Screening Strategies for Colorectal Cancer: Patient Response and Detection Rates,” Journal of the National Cancer Institute, Vol. 97, No. 5, 2005, pp. 347-357. doi:10.1093/jnci/dji050
 M. B. Goetz, T. Hoang, C. Bowman, et al., “A System-Wide Intervention to Improve HIV Testing in the Veterans Health Administration,” Journal of General Internal Medicine, Vol. 23, No. 8, 2008, pp. 1200-1207. doi:10.1007/s11606-008-0637-6
 F. Ketema, C. Zeh, D. C. Edelman, R. Saville and N. T. Constantine, “Assessment of the Performance of a Rapid, Lateral Flow Assay for the Detection of Antibodies to HIV,” Journal of Acquired Immune Deficiency Syndromes, Vol. 27, No. 1, 2001, pp. 63-70. doi:10.1097/00126334-200105010-00011
 Abbott Laboratories, “HIVAB HIV-1/HIV-2 (rDNA) EIA Package Insert,” 2011. http://www.fda.gov/downloads/BiologicsBloodVaccines/ BloodBloodPrducts/ApprovedProducts/LicensedProducts BLAs/BloodDonorScreening/InfectiousDisease/UCM091153.pdf